Omega Diagnostics shares gain 6% as investors cheer exit from Covid testing
- Preferred bidder selected for sale of CD4 manufacturing business
- Substantial up-front payment and royalties expected
- Focus now on higher margin Health & Nutrition
Specialist medical diagnostics firm Omega Diagnostics (ODX:AIM) said it had selected a preferred bidder after receiving several indicative offers for its CD4 Advanced Disease testing business.
The bidder has been ...